OPKO Health, Inc. Line of Credit Facility, Maximum Borrowing Capacity
OPKO Health, Inc. (OPK) had Line of Credit Facility, Maximum Borrowing Capacity of $30.40 million as of 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Notes › Debt
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2026-08-28
- 2026-06-30: Line of Credit Facility, Maximum Borrowing Capacity $30.40M.
- 2026-03-31: Line of Credit Facility, Maximum Borrowing Capacity $30.41M.
- 2025-12-31: Line of Credit Facility, Maximum Borrowing Capacity $30.44M.
- 2025-09-30: Line of Credit Facility, Maximum Borrowing Capacity $31.02M.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2026-06-30 | $30.40M 10-Q/A · filed 2026-08-28 |
| 2026-03-31 | $30.41M 10-Q/A · filed 2026-08-28 |
| 2025-12-31 | $30.44M 10-K · filed 2026-02-26 |
| 2025-09-30 | $31.02M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $31.55M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $30.89M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $30.82M 10-K · filed 2025-03-03 |
| 2024-09-30 | $30.01M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $79.87M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $79.88M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $80.37M 10-K · filed 2024-03-01 |
| 2023-09-30 | $80.16M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $80.03M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $104.89M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $105.35M 10-K · filed 2023-02-27 |
| 2022-09-30 | $104.78M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $104.84M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $103.20M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $103.36M 10-K · filed 2022-03-01 |
| 2021-09-30 | $103.77M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $106.26M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $105.80M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $101.69M 10-K · filed 2021-02-18 |
| 2020-09-30 | $100.97M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $101.31M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $98.66M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $97.76M 10-K · filed 2020-03-02 |
| 2019-09-30 | $122.44M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $122.48M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $197.17M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $197.19M 10-K · filed 2019-03-01 |
| 2018-09-30 | $197.23M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $196.90M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $197.41M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $197.32M 8-K · filed 2019-01-29 |
| 2017-09-30 | $196.81M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $191.08M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $190.72M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $190.71M 10-K · filed 2017-03-01 |
| 2016-09-30 | $190.73M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $190.73M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $189.48M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $189.82M 10-K · filed 2016-02-29 |
| 2015-09-30 | $134.96M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $13.87M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $13.26M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $13.12M 10-K · filed 2015-02-27 |
| 2014-09-30 | $13.15M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $14.35M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $14.56M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $14.52M 10-K · filed 2014-03-03 |
| 2013-09-30 | $16.99M 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |